- Report
- May 2025
- 192 Pages
Global
From €3140EUR$3,545USD£2,721GBP
€3489EUR$3,939USD£3,023GBP
- Report
- May 2025
- 193 Pages
Global
From €3140EUR$3,545USD£2,721GBP
€3489EUR$3,939USD£3,023GBP
- Report
- May 2025
- 183 Pages
Global
From €3140EUR$3,545USD£2,721GBP
€3489EUR$3,939USD£3,023GBP
- Report
- March 2025
- 200 Pages
Global
From €3977EUR$4,490USD£3,446GBP
- Report
- July 2025
- 267 Pages
Global
From €5182EUR$5,850USD£4,490GBP
- Report
- July 2025
- 466 Pages
Global
From €5182EUR$5,850USD£4,490GBP
- Report
- July 2025
- 269 Pages
Global
From €5182EUR$5,850USD£4,490GBP
- Report
- July 2025
- 135 Pages
Global
From €5182EUR$5,850USD£4,490GBP
- Report
- November 2024
- 180 Pages
Global
From €3388EUR$3,825USD£2,936GBP
€3986EUR$4,500USD£3,454GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1329EUR$1,500USD£1,151GBP
- Report
- June 2025
- 200 Pages
Global
From €2471EUR$2,789USD£2,141GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2471EUR$2,789USD£2,141GBP
- Report
- August 2024
- 150 Pages
Global
From €2471EUR$2,789USD£2,141GBP
- Report
- August 2024
- 150 Pages
Global
From €2471EUR$2,789USD£2,141GBP
- Report
- April 2025
- 236 Pages
Global
From €2215EUR$2,500USD£1,919GBP
- Report
- January 2020
- 300 Pages
Global
From €2923EUR$3,300USD£2,533GBP
- Report
- July 2022
- 2190 Pages
Global
From €3189EUR$3,600USD£2,763GBP
- Report
- June 2024
- 310 Pages
Global
From €2170EUR$2,450USD£1,880GBP
- Report
- July 2022
- 200 Pages
Global
From €3698EUR$4,175USD£3,205GBP
- Report
- July 2024
- 150 Pages
Global
From €3322EUR$3,750USD£2,878GBP

The Cancer Drug Development market is a subset of the larger Drug Discovery industry. It focuses on the development of drugs to treat cancer, a disease that affects millions of people worldwide. This market includes the research and development of new drugs, as well as the testing and approval of existing drugs for use in cancer treatment. Companies in this market must adhere to strict regulations and guidelines set by regulatory bodies such as the US Food and Drug Administration (FDA).
The Cancer Drug Development market is highly competitive, with many companies vying for a share of the market. Companies in this market include large pharmaceutical companies, biotechnology companies, and smaller start-ups. Examples of companies in this market include AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer, and Roche. Show Less Read more